APA (7th ed.) Citation

Guo, Z., Tu, S., Yu, S., Wu, L., Pan, W., Chang, N., . . . He, Y. (2021). Preclinical and clinical advances in dual‐target chimeric antigen receptor therapy for hematological malignancies. Cancer science, 112(4), 1357-1368. https://doi.org/10.1111/cas.14799

Chicago Style (17th ed.) Citation

Guo, Zhenling, et al. "Preclinical and Clinical Advances in Dual‐target Chimeric Antigen Receptor Therapy for Hematological Malignancies." Cancer Science 112, no. 4 (2021): 1357-1368. https://doi.org/10.1111/cas.14799.

MLA (9th ed.) Citation

Guo, Zhenling, et al. "Preclinical and Clinical Advances in Dual‐target Chimeric Antigen Receptor Therapy for Hematological Malignancies." Cancer Science, vol. 112, no. 4, 2021, pp. 1357-1368, https://doi.org/10.1111/cas.14799.